It’s much more than 5-hour energy jolt. Cardium Therapeutics’ purchase of To Go Brands and its sales network will help Cardium get much more of the $30 billion supplements market:
Here's my story on the acquisition:
sandiegobiotechnology.com
Cardium's acquisition is expected to expand sales of its in-house MedPodium health sciences nutraceutical brand platform because To Go Brands has a nationwide marketing network that includes Whole Foods, CVS, Kroger, GNC, Jewel-Osco, Ralph’s Supermarkets, the Vitamin Shoppe and other food, drug and mass retail outlets.
The acquisition is part of Cardium’s diversified business strategy, which is designed to balance a higher-risk and potentially higher-return products with lower-risk opportunities. In addition to the MedPodium product line, Cardium’s gene-therapy candidate Generx is in late-stage clinical trials and the company’s FDA-cleared Excellagen, is an advanced wound care product that supports the healing of skin ulcers common among diabetics, and other dermal wounds.
The National Business Journal said its 2012 Supplement Business Report, release Oct. 1, 2012, reports that the dietary supplements industry surpassed $30 billion in 2011 sales, up 7 percent from the previous year. The increase is a positive feature of the merchandise landscape for grocery stores, drugstores and mass market retailers such as Walmart.
|
